FDG autoradiography reveals developmental and pathological effects of mutant amyloid in PDAPP transgenic mice

Transgenic mouse models of Alzheimer's disease (AD) show some characteristic features of the disease, and we aim to further bridge the gap between studies of humans with AD, those at risk, and these murine models by providing shared markers of disease which could be used to track progression and assess future interventions. Brain imaging measurements may prove useful in this regard. We previously found that the homozygous PDAPP mouse model of AD showed significant declines in glucose uptake with age in posterior cingulate cortex (PCC), an area homologous to the human posterior cingulate, which shows significant declines in AD and in those at risk for AD. To further evaluate this potential biomarker and its correlation across age, we used fluorodeoxyglucose (FDG) autoradiography at two ages (2 and 12 months) in wildtype, heterozygous, and homozygous PDAPP mice. We found significant posterior cingulate fluorodeoxyglucose uptake declines again in homozygous PDAPP mice, but at both ages assessed. There was a strong effect of gene dose; homozygous mice showed larger and earlier effects. These results, in conjunction with our previous analyses, indicate a nonlinear progression stemming from synergistic effects of the overexpressed mutant gene, both developmental and pathological. The posterior cingulate is preferentially vulnerable to both effects of transgene in the PDAPP mouse, and both are independent of amyloid deposition.

[1]  F. Bloom,et al.  Amyloid deposition in the hippocampus and entorhinal cortex: Quantitative analysis of a transgenic mouse model , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[2]  F Gonzalez-Lima,et al.  Energy Hypometabolism in Posterior Cingulate Cortex of Alzheimer's Patients: Superficial Laminar Cytochrome Oxidase Associated with Disease Duration , 2001, The Journal of Neuroscience.

[3]  F. Gonzalez-Lima,et al.  Reduced corpus callosum, fornix and hippocampus in PDAPP transgenic mouse model of Alzheimer's disease , 2001, Neuroreport.

[4]  G L Shulman,et al.  INAUGURAL ARTICLE by a Recently Elected Academy Member:A default mode of brain function , 2001 .

[5]  S. Thibodeau,et al.  Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. , 1996, The New England journal of medicine.

[6]  Eric M. Reiman,et al.  Age- and transgene-related changes in regional cerebral metabolism in PSAPP mice , 2006, Brain Research.

[7]  Guiquan Chen,et al.  A learning deficit related to age and β-amyloid plaques in a mouse model of Alzheimer's disease , 2000, Nature.

[8]  A. Toga,et al.  Tracking Alzheimer's Disease , 2007, Annals of the New York Academy of Sciences.

[9]  H. Nogami,et al.  Regional expression of a gene encoding a neuron-specific Na(+)-dependent inorganic phosphate cotransporter (DNPI) in the rat forebrain. , 2000, Brain research. Molecular brain research.

[10]  Postnatal development of cytochrome oxidase activity in fiber tracts of the rat brain. , 1999, Brain research. Developmental brain research.

[11]  C. Almeida,et al.  Intraneuronal Abeta accumulation and origin of plaques in Alzheimer's disease. , 2005, Neurobiology of aging.

[12]  Majaz Moonis,et al.  Amyloid Deposition Begins in the Striatum of Presenilin-1 Mutation Carriers from Two Unrelated Pedigrees , 2007, The Journal of Neuroscience.

[13]  M. Gabriel,et al.  Hippocampal control of cingulate cortical and anterior thalamic information processing during learning in rabbits , 2004, Experimental Brain Research.

[14]  Anthony R. McIntosh,et al.  Age-Related Differences in Neural Activity during Memory Encoding and Retrieval: A Positron Emission Tomography Study , 1997, The Journal of Neuroscience.

[15]  E. Tulving,et al.  Network Analysis of Positron Emission Tomography Regional Cerebral Blood Flow Data: Ensemble Inhibition during Episodic Memory Retrieval , 1996, The Journal of Neuroscience.

[16]  Chantal Mathis,et al.  Early regional cerebral glucose hypometabolism in transgenic mice overexpressing the V717F β-amyloid precursor protein , 1999, Neuroscience Letters.

[17]  C. Almeida,et al.  Intraneuronal Aβ accumulation and origin of plaques in Alzheimer's disease , 2005, Neurobiology of Aging.

[18]  P. Greengard,et al.  The Amyloid Precursor Protein and Its Regulatory Protein, FE65, in Growth Cones and Synapses In Vitro and In Vivo , 2003, The Journal of Neuroscience.

[19]  L. Mucke,et al.  Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein , 1995, Nature.

[20]  F. Gonzalez-Lima,et al.  Nonprogressive transgene-related callosal and hippocampal changes in PDAPP mice , 2006, Neuroreport.

[21]  N. Foster,et al.  Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease , 1997, Annals of neurology.

[22]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[23]  Satoshi Minoshima,et al.  Posterior cingulate cortex in Alzheimer's disease , 1994, The Lancet.

[24]  J. Hardy,et al.  Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes , 1998, Nature Medicine.

[25]  M. W. Brown,et al.  Fos expression in the rostral thalamic nuclei and associated cortical regions in response to different spatial memory tests , 2000, Neuroscience.

[26]  D. Bredesen,et al.  Correction for Galvan et al., Reversal of Alzheimer's-like pathology and behavior in human APP transgenic mice by mutation of Asp664 , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[27]  F Gonzalez-Lima,et al.  Tracking Alzheimer's disease in transgenic mice using fluorodeoxyglucose autoradiography , 2000, Neuroreport.